Not applicableNot Yet RecruitingNCT06902025What this trial is testingJY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell LeukemiaWho this might be right forB-ALL He Huang 24
Large-scale testing (Phase 3)Ended earlyNCT00416910What this trial is testingCombination Chemotherapy With or Without G-CSF in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia German CLL Study Group 83
Early research (Phase 1)Study completedNCT02529813What this trial is testingCD19-Specific T-cells in Treating Patients With Advanced Lymphoid MalignanciesWho this might be right forAcute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaBlasts 5 Percent or More of Bone Marrow Nucleated Cells+6 more M.D. Anderson Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00230282What this trial is testingPhase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaB-cell LeukemiaChronic Leukemia+1 more Steven E. Coutre 25
Large-scale testing (Phase 3)UnknownNCT00445497What this trial is testingEarly Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile NeutropeniaWho this might be right forBrain and Central Nervous System TumorsLymphomaNeutropenia+3 more Clatterbridge Centre for Oncology 400
Early research (Phase 1)Active Not RecruitingNCT00881920What this trial is testingKappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALLWho this might be right forLymphomaMyelomaLeukemia Baylor College of Medicine 54
Not applicableUnknownNCT02267590What this trial is testingTissue Collection for Biomarkers Determining Resistance to IbrutinibWho this might be right forMantle Cell LymphomaChronic Lymphocytic Leukaemia Royal Marsden NHS Foundation Trust 120
Testing effectiveness (Phase 2)Study completedNCT01024010What this trial is testingOfatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forChronic Lymphocytic LeukemiaStage 0 Chronic Lymphocytic LeukemiaStage I Chronic Lymphocytic Leukemia+7 more Mayo Clinic 82
Early research (Phase 1)Study completedNCT00390117What this trial is testingAT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphomaUnspecified Adult Solid Tumor, Protocol Specific NCIC Clinical Trials Group 34
Not applicableStudy completedNCT04964908What this trial is testingStudy to Understand Clinical Characteristics, Treatment Pathway in Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia AstraZeneca 1,088
Testing effectiveness (Phase 2)WithdrawnNCT06247540What this trial is testingVenetoclax, Rituximab and Nivolumab in Combination for the Treatment of Richter's Transformation Arising From Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaWho this might be right forRecurrent Transformed Chronic Lymphocytic LeukemiaRefractory Transformed Chronic Lymphocytic LeukemiaRichter Syndrome+2 more Northwestern University
Early research (Phase 1)Study completedNCT00868413What this trial is testingStudy of ABT-263 When Administered in Combination With Either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/Rituximab in Relapsed or Refractory Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia AbbVie (prior sponsor, Abbott) 32
Early research (Phase 1)Study completedNCT01399840What this trial is testingStudy of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological MalignanciesWho this might be right forAcute Myeloid LeukemiaMyelodysplastic SyndromeChronic Lymphocytic Leukemia+1 more Pfizer 33
Not applicableStudy completedNCT03425591What this trial is testingIbrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical PracticeWho this might be right forLeukemia, Lymphocytic, Chronic, B-CellLymphoma, Mantle-Cell Janssen-Cilag Ltd. 508
Post-approval studies (Phase 4)Study completedNCT01056510What this trial is testingMabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)Who this might be right forLymphocytic Leukemia, Chronic Hoffmann-La Roche 357
Testing effectiveness (Phase 2)Ended earlyNCT00265928What this trial is testingBortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's LymphomaWho this might be right forLymphoma University of Virginia 46
Testing effectiveness (Phase 2)Study completedNCT01066663What this trial is testingPyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Leukemia Dana-Farber Cancer Institute 20
Not applicableStudy completedNCT00281801What this trial is testingCaregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow TransplantationWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Case Comprehensive Cancer Center 168
Testing effectiveness (Phase 2)Study completedNCT00096044What this trial is testingLenalidomide With or Without Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaWho this might be right forLeukemia Roswell Park Cancer Institute 45
Early research (Phase 1)WithdrawnNCT03884972What this trial is testingTrabectedin and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Resistant or Intolerant to a BTK InhibitorWho this might be right forRefractory Chronic Lymphocytic LeukemiaRefractory Small Lymphocytic Lymphoma M.D. Anderson Cancer Center